We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

HUYA Bioscience International and Chipscreen Biosciences Initiate a Phase I Clinical Cancer Trial

News   May 24, 2007

 
HUYA Bioscience International and Chipscreen Biosciences Initiate a Phase I Clinical Cancer Trial
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Novel Strategy Generates Useful Compounds for Drug Synthesis

News

A team of scientists has designed a novel catalytic method that can generate useful chiral compounds. This new strategy could provide an effective synthetic way to design pharmaceutical products.

READ MORE

Molecules Identified That Shut Down SARS-CoV-2 Polymerase Reaction

News

Researchers have discovered a library of molecules with unique structural and chemical features, capable of inhibiting the SARS-CoV-2 polymerase.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE